Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer

Clinical trial NCT06518226 · RECRUITING

Trial details

NCT number: NCT06518226
Sponsor: UMC Utrecht
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer Prostate Adenocarcinoma Localized Prostate Carcinoma

Start date: 2024-03-28
Primary completion: 2026-07-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.